Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
Bayer Drug Development Simulation Brings the Realities of Pharmaceutical R&D to Life
As part of the iCANPOD/iCANDOC Workshop Series: Perspectives in Precision Cancer Medicine inand Outside Academia, iCANDOC hosted the Bayer Drug…
iCAN Science Meetup
Welcome to the iCAN Science Meetup with poster exhibition November 25, 2026 at 14.00-18.30 in Biomedicum Lecture Hall 1 Register…
TRIMM x iCAN seminar with Dr Carlos Figueiredo
Dr Figueiredo is a recognized biomedical scientist and a Docent of Immunology. We are happy to organise a seminar together with Translational…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
